CYTORI THERAPEUTICS, INC. Business Finance Contracts & Agreements
107 Contracts & Agreements
- Investment Agreements (1 contract)
- Loan Agreements (20)
- Note Agreements (4)
- Pledge Agreements (1)
- Purchase Agreements (14)
- Registration Rights Agreements (5)
- Release Agreements (2)
- Repurchase Agreements (1)
- Security Agreements (1)
- Share Agreements (1)
- Stock Agreements (21)
- Subscription Agreements (3)
- Underwriting Agreements (4)
- Warrant Agreements (29)
- Tenth Amendment to Loan and Security Agreement (Filed With SEC on August 14, 2023)
- Subscription and Investment Representation Agreement, dated March 3, 2023, by and between Plus Therapeutics, Inc. and the purchaser signatory thereto (Filed With SEC on March 3, 2023)
- Purchase Agreement, dated August 2, 2022, by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 8, 2022)
- Registration Rights Agreement, dated August 2, 2022, by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 8, 2022)
- Purchase Agreement, dated September 30, 2020 by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 6, 2020)
- Registration Rights Agreement, dated September 30, 2020 by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 6, 2020)
- Form of Underwriter Warrant Amendment Agreement (Filed With SEC on October 5, 2020)
- Form of Warrant Amendment Agreement (Filed With SEC on April 23, 2020)
- Ninth Amendment to the Loan and Security Agreement, dated March 29, 2020, between Plus Therapeutics, Inc. and Oxford Finance LLC (Filed With SEC on March 30, 2020)
- Form of Underwriting Agreement (Filed With SEC on September 16, 2019)
- Form of Series U Warrant (Filed With SEC on September 16, 2019)
- Form of Series V Warrant (Filed With SEC on September 16, 2019)
- Seventh Amendment to Loan and Security Agreement, effective as of April 24, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 15, 2019)
- Eighth Amendment to Loan and Security Agreement, effective as of July 15, 2019, by and between Plus Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 15, 2019)
- Seventh Amendment to Loan and Security Agreement, effective as of April 24, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on May 14, 2019)
- Asset and Share Sale and Purchase Agreement, dated as of April 19, 2019, by and between Cytori Therapeutics, Inc. and Seijir Shirahama (Filed With SEC on April 23, 2019)
- Fifth Amendment to Loan and Security Agreement dated February 13, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on March 29, 2019)
- Sixth Amendment to Loan and Security Agreement dated March 4, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on March 29, 2019)
- Fourth Amendment to Loan and Security Agreement dated December 31, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on February 1, 2019)
- Third Amendment to Loan and Security Agreement, dated August 31, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on September 21, 2018)
- Second Amendment to Loan and Security Agreement, dated June 19, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 14, 2018)
- Form of Common Stock Certificate (Filed With SEC on March 9, 2018)
- RESTATED WARRANT AGENT AGREEMENT (Filed With SEC on August 11, 2017)
- CYTORI THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 12, 2017)
- COMMON STOCKPURCHASE WARRANT CYTORI THERAPEUTICS, INC. (Filed With SEC on April 12, 2017)
- ASSET PURCHASE AGREEMENT by and between Cytori Therapeutics, Inc. and Azaya Therapeutics, Inc. January 16, 2017 TABLE OF CONTENTS (Filed With SEC on March 24, 2017)
- PURCHASE AGREEMENT (Filed With SEC on December 29, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 29, 2016)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on May 11, 2016)
- [Form of Warrant Certificate] [FACE] (Filed With SEC on May 11, 2016)
- WARRANT AGENT AGREEMENT (Filed With SEC on May 11, 2016)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on April 6, 2016)
- Amendment to Common Stock Purchase Warrant (Filed With SEC on March 11, 2016)
- Amendment to Series A-1 Warrant to Purchase Common Stock (Filed With SEC on March 11, 2016)
- Amendment to Series A-2 Warrant to Purchase Common Stock (Filed With SEC on March 11, 2016)
- Amendment One to the Securities Purchase Agreement between the Company and certain institutional investors dated May 5, 2015 (Filed With SEC on March 11, 2016)
- Loan and Security Agreement, dated May 29, 2015, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 10, 2015)
- Amendment One to the Securities Purchase Agreement, dated March 16, 2015, between the Company and certain institutional investors (Filed With SEC on May 11, 2015)
- [FORM OF SERIES A-1 WARRANT] (Filed With SEC on May 5, 2015)
- [FORM OF SERIES A-2 WARRANT] (Filed With SEC on May 5, 2015)
